Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus Cardiovasc

By Manfredi Samantha   Calvi Debora   del Fiandra Martina   Botto Nicoletta   Biagini Andrea   Andreassi Maria Grazia  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 29-34

Future Medicine

Access to resources Recommend Favorite

Serum Uric Acid and Risk of Coronary Heart Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4125-4132

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-06 ,pp. : 2037-2048

Bentham Science Publishers

Access to resources Recommend Favorite